| Literature DB >> 23447694 |
Fengling Wang1, Zhitong Bing, Yanan Zhang, Bin Ao, Sheng Zhang, Caiyong Ye, Jinpeng He, Nan Ding, Wenling Ye, Jie Xiong, Jintu Sun, Yoshiya Furusawa, Guangming Zhou, Lei Yang.
Abstract
Melanoma is a malignant tumor with high invasive and metastatic properties. Though radiation is the major therapy for melanoma, its radio-resistance has been shown to severely influence the clinical outcome. So it is imperative to enhance the sensitivity of uveal melanoma cells to radiotherapy. Previously, we found that the cell cycle of 92-1 uveal melanoma cells was suspended and remained unchanged for up to 5 days after exposure to 10 Gy of X-rays, which might be relevant to the high radio-sensitivity of 92-1 cells. To further investigate the cell cycle suspension-associated proteins, we employed two analyses with stable isotope labeling with amino acids in cell culture technology and two-dimensional liquid chromatography tandem mass spectrometry. Cells were incubated for 15 h or 48 h after irradiation with 10 Gy of X-rays. We identified a total of 737 proteins at 15 h (Group A) and 530 proteins at 48 h post-irradiation (Group B). The gene ontology biological pathway was used to obtain a systems level view of proteome changes in 92-1cells under cell cycle suspension. We further selected the significantly changed proteins for investigation of their potential contribution to cell cycle suspension, growth arrest and cell senescence. These proteins are involved in the cell cycle, stress response, glycolysis and the tricarboxylic acid cycle, etc. Our study expected to reveal potential marker proteins associated with cell suspension induced by irradiation, which might contribute to understanding the mechanism beyond the cell cycle suspension.Entities:
Keywords: 2D-LC-MS/MS; GO biological pathway; radiation; uveal melanoma
Mesh:
Substances:
Year: 2013 PMID: 23447694 PMCID: PMC3709680 DOI: 10.1093/jrr/rrt010
Source DB: PubMed Journal: J Radiat Res ISSN: 0449-3060 Impact factor: 2.724
Fig. 1.The work flow of protein identification and quantification. For the SILAC experiments, the control cells were cultured in Dulbecco's Modified Eagle's Medium containing ‘heavy’ 13C615N4-L-arginine and 13C615N2-L-lysine, while irradiation group cells were maintained in normal ‘light’ medium containing 12C614N4-L-arginine and 12C614N2-L-lysine. The mixtures of Group A and Group B were analyzed by mass spectrum and then explained by SEQUEST.
Fig. 2.Heat map generated from forward and reverse SILAC data in Group A. Reverse SILAC means that sham control cells were labeled with ‘light’ amino acids while irradiated cells with ‘heavy’ amino acids. Forward SILAC means that irradiated cells were labeled with ‘light’ amino acids while control cells were labeled with ‘heavy’ amino acids.
Fig. 3.The expression level changes of XRCC5 and XRCC6 by western blot analysis at 15 h and 48 h post-irradiation.
Comparisons of the protein ratio obtained from western blots and SILAC-MS analysis
| Protein name | Normalized ratio of western blot | Mean ASAP ratio of SILAC | ||
|---|---|---|---|---|
| 15 h/Ctrl | 48 h/Ctrl | 15 h/Ctrl | 48 h/Ctrl | |
| 0.80 ± 0.21 | 0.68 ± 0.18 | 0.86 ± 0.24 | 0.49 ± 0.25 | |
| 0.71 ± 0.19 | 0.66 ± 0.04 | 0.64 ± 0.54 | 0.77 ± 0.11 | |
Gray intensity analysis for western blot was measured with Photoshop CS. The value was then normalized using the levels of β-actin. Average normalized value was presented from three independent experiments. MS = mass spectrum.
Fig. 4A.Distribution of protein ASAP ratio (irradiated/control) for the quantified proteins in Group A and Group B. The distribution of proteins quantified by ASAP ratio and the threshold of fold change was cut off ± 1.25.
Partial list of the overlap proteins identified with more than two-fold changes in one SILAC experiment at least
| NP number | Protein name | Gene name | 15 h mean ASAP ratio | 48 h mean ASAP ratio |
|---|---|---|---|---|
| NP_036457.1 | microtubule-associated protein | MAPRE1 | 0.47 | 0.17 |
| NP_001099008.1 | Myb-binding protein 1A | MYBBP1A | 3.54 | 0 |
| NP_631946.1 | nucleosome assembly protein 1-like 1 | NAP1L1 | 0.32 | 0.73 |
| NP_005960.1 | nucleosome assembly protein 1-like 4 | NAP1L4 | 0.18 | 0 |
| NP_002625.1 | Prohibitin 1 | PHB1 | 0.69 | 0.41 |
| NP_009204.1 | prohibitin 2 | PHB2 | 0.88 | 0.1 |
| NP_008835.5 | DNA-dependent protein kinase catalytic subunit | PRKDC | 0.67 | 0.74 |
| NP_002806.2 | proteasome 26S non-ATPase subunit 11 | PSMD11 | 0.33 | 0.82 |
| NP_002802.2 | 26S proteasome non-ATPase regulatory subunit 7 | PSMD7 | 0.48 | 0.82 |
| NP_005611.1 | Protein S100-A11 | S100A11 | 0.77 | 0.54 |
| NP_005110.2 | thyroid hormone receptor associated protein 3 | THRAP3 | 0.67 | 0.42 |
| NP_003395.1 | 14-3-3 protein beta/alpha | YWHAB | 0.33 | 0.18 |
| NP_006752.1 | 14-3-3 protein epsilon | YWHAE | 0.62 | 0.33 |
| NP_056060.2 | Ankyrin repeat and SAM domain-containing protein 1A | ANKS1A | 1.04 | 0.47 |
| NP_003320.2 | Thioredoxin | TXN | 0.35 | 0.04 |
| NP_110437.2 | Thioredoxin domain-containing protein 5 | TXNDC5 | 0.55 | 0.45 |
| NP_054817.2 | peroxiredoxin 3 | PRDX3 | 0.36 | 0.36 |
| NP_036226.1 | peroxiredoxin 5 | PRDX5 | 0.58 | 0 |
| NP_057376.2 | TNF receptor-associated protein 1 | TRAP1 | 4.04 | 0.49 |
| NP_006358.1 | adenylyl cyclase-associated protein | CAP1 | 0.67 | 0.53 |
| NP_000601.3 | CD44 antigen | CD44 | 0.53 | 0.56 |
| NP_002005.1 | FK506-binding protein 4 | FKBP4 | 0.25 | 0.41 |
| NP_003290.1 | heat shock protein 90kDa beta | HSP90B1 | 0.56 | 0.9 |
| NP_005337.2 | Heat shock 70 kDa protein 1A/1B | HSPA1B | 0.53 | 0 |
| NP_006588.1 | heat shock 70kDa protein 8 | HSPA8 | 0.41 | 0.33 |
| NP_004125.3 | heat shock 70kDa protein 9 | HSPA9 | 0.73 | 0.51 |
| NP_001531.1 | heat shock 27kDa protein 1 | HSPB1 | 0.71 | 2.05 |
| NP_002147.2 | heat shock protein 60 kDa | HSPD1 | 0.54 | 0.43 |
| NP_006635.2 | heat shock protein 105 kD | HSPH1 | 0.82 | 1.18 |
| NP_002297.2 | galectin 3 | LGALS3 | 0.67 | 0.56 |
| NP_110437.2 | X-ray repair cross-complementing protein 5 | XRCC5/ku86 | 0.86 | 0.49 |
| NP_001460.1 | X-ray repair cross-complementing protein 6 | XRCC6/ku70 | 0.64 | 0.77 |
| NP_002037.2 | glyceraldehyde-3-phosphate dehydrogenase | GAPDH | 0.30 | 1.8 |
| NP_002291.1 | lactate dehydrogenase B | LDHB | 0.54 | 1.53 |
| NP_000166.2 | glucose phosphate isomerase | GPI | 0.68 | 1.24 |
| NP_000282.1 | phosphoglycerate kinase 1 | PGK1 | 0.62 | 1.1 |
| NP_000356.1 | Triosephosphate isomerase | TPI1 | 0.65 | 1.09 |
| NP_005557.1 | lactate dehydrogenase A | LDHA | 0.56 | 1.01 |
| NP_002645.3 | pyruvate kinase | PKM2 | 0.64 | 0.83 |
| NP_001419.1 | enolase 1 | ENO1 | 0.39 | 0.53 |
| NP_908930.1 | aldolase A | ALDOA | 0.39 | 0.43 |
| NP_061820.1 | cytochrome c | CYCS | 0.30 | 0.96 |
| NP_000099.2 | dihydrolipoamide dehydrogenase | DLD | 0.46 | 999 |
| NP_001089.1 | aconitase 2 | ACO2 | 0.34 | 2.63 |
| NP_004159.2 | succinate dehydrogenase complex, subunit A | SDHA | 0.89 | 2.06 |
| NP_001087.2 | ATP citrate lyase isoform 1 | ACLY | 0.60 | 1.68 |
| NP_036475.3 | nicotinamide nucleotide transhydrogenase | NNT | 0.71 | 1.33 |
| NP_000134.2 | fumarate hydratase | FH | 0.47 | 1.04 |
| NP_005909.2 | mitochondrial malate dehydrogenase | MDH2 | 0.41 | 0.87 |
| NP_004994.1 | Acyl carrier protein | NDUFAB1 | 0.30 | 2.89 |
| NP_003356.2 | Cytochrome b-c1 complex subunit 1 | UQCRC1 | 0.66 | 0.92 |
| NP_001677.2 | ATP synthase | ATP5B | 0.61 | 0.85 |
| NP_003357.2 | Cytochrome b-c1 complex subunit 2 | UQCRC2 | 0.57 | 0.83 |
| NP_001015.1 | ribosomal protein S21 | RPS21 | 0.90 | 0.23 |
| NP_000979.1 | ribosomal protein L27 | RPL27 | 0.55 | 0.38 |
| NP_056474.2 | ribosomal L1 domain containing 1 | RSL1D1 | 0.40 | 0.41 |
| NP_000958.1 | ribosomal protein L3 | RPL3 | 0.88 | 0.44 |
| NP_002286.2 | ribosomal protein SA | RPSA | 0.87 | 0.51 |
| NP_150254.1 | ribosomal protein L13 | RPL13 | 1.48 | 0.55 |
| NP_006351.2 | eukaryotic translation initiation factor 3 | EIF3M | 0.59 | 0.86 |
| NP_001016.1 | ribosomal protein S23 | RPS23 | 0.47 | 0.89 |
| NP_001408.2 | eukaryotic translation initiation factor 4B | EIF4B | 0.45 | 0.9 |
| NP_004437.2 | glutamyl-prolyl tRNA synthetase | EPRS | 0.48 | 0.91 |
| NP_001002.1 | ribosomal protein S7 | RPS7 | 0.62 | 0.94 |
| NP_000959.2 | ribosomal protein L4 | RPL4 | 0.68 | 1.08 |
| NP_004085.1 | Eukaryotic translation initiation factor 2 subunit 1 | EIF2S1 | 0.10 | 1.13 |
| NP_002939.2 | ribosomal protein L15 | RPL15 | 0.34 | 1.19 |
| NP_444505.1 | ribosomal protein P0 | RPLP0 | 0.17 | 1.55 |
| NP_000996.2 | ribosomal protein S3 | RPS3 | 0.53 | 1.59 |
| NP_000960.2 | ribosomal protein L5 | RPL5 | 0.37 | 3.65 |
| NP_001393.1 | Elongation factor 1-alpha 1 | EEF1A1 | 0.50 | 0.27 |
| NP_001395.1 | Elongation factor 1-gamma | EEF1G | 0.60 | 1.29 |
| NP_006102.2 | acetyl-coenzyme A acyltransferase 2 | ACAA2 | 0.84 | 0.45 |
| NP_005989.3 | chaperonin containing TCP1, subunit 3 | CCT3 | 0.30 | 1.32 |
| NP_036205.1 | chaperonin containing TCP1, subunit 5 | CCT5 | 0.50 | 1.43 |
| NP_001753.1 | chaperonin containing TCP1, subunit 6A | CCT6A | 0.60 | 0.91 |
| NP_006420.1 | chaperonin containing TCP1, subunit 7 | CCT7 | 0.39 | 999 |
| NP_006576.2 | chaperonin containing TCP1, subunit 8 | CCT8 | 0.67 | 0.56 |
| NP_005498.1 | cofilin 1 | CFL1 | 0.23 | 0.9 |
| NP_004081.1 | dual specificity phosphatase 3 | DUSP3 | 0.03 | 0.06 |
| NP_004437.2 | glutamyl-prolyl tRNA synthetase | EPRS | 0.48 | 0.91 |
| NP_006699.2 | glyoxalase I | GLO1 | 0.49 | 1.07 |
| NP_001035807.1 | Histone H2A type 2-A | HIST2H2AA4 | 0.43 | 0.95 |
| NP_036350.2 | Interleukin enhancer-binding factor 3 | ILF3 | 0.27 | 3.65 |
| NP_002406.1 | macrophage migration inhibitory factor | MIF | 0.37 | 1.02 |
| NP_005372.2 | nucleolin | NCL | 0.16 | 0.86 |
| NP_683877.1 | proteasome alpha 1 subunit | PSMA1 | 0.58 | 0.98 |
| NP_002788.1 | proteasome beta 5 subunit | PSMB5 | 0.62 | 4.13 |
| NP_006494.1 | proteasome 26S ATPase subunit 4 | PSMC4 | 0.54 | 0.77 |
| NP_002806.2 | proteasome 26S non-ATPase subunit 11 | PSMD11 | 0.33 | 0.82 |
| NP_002825.3 | protein tyrosine phosphatase, non-receptor type 11 | PTPN11 | 0.22 | 1.95 |
| NP_006316.1 | ras-related nuclear protein | RAN | 0.54 | 0.51 |
| NP_005057.1 | splicing factor proline/glutamine rich | SFPQ | 0.78 | 1.71 |
| NP_004243.1 | solute carrier family 9 | SLC9A3R1 | 0.00 | 0.36 |
| NP_005753.1 | tripartite motif-containing 28 protein | TRIM28 | 0.47 | 0.77 |
| NP_003339.1 | ubiquitin-conjugating enzyme E2N | UBE2N | 0.49 | 2.55 |
In Table 2, ‘0’ indicates that the peptides were not detected in the irradiated cells, but ‘999’ indicates that the peptides were not detected in the control cells. TCA = tricarboxylic acid.
Fig. 4C.Distribution of proteins down- and up-regulated by two-fold or more in each biological process. The abbreviations in the graph are as follows: cell communication (CC), cellular process (CP), cellular component organization (CCO), system process (SP), response to stimulus (RS), developmental process (DP), metabolic process (MP), immune system process (ISP).
Fig. 4B.Gene ontology (GO) analysis of the proteins identified in group A and Group B. Pie charts (A) and (C) show proteins classified on the basis of biological processes for Group A and Group B, respectively. Pie charts (B) and (D) show proteins classified according to molecular function for Group A and Group B, respectively.
Fig. 5.Enriched biological pathways for the overlap proteins identified in Group A and Group B. Different biological pathway terms for proteins with changed expression levels analyzed by Database for Annotation, Visualization and Integrated Discovery. (A) Biological pathway terms associated with down-regulated proteins at 15 h and 48 h post-irradiation (down-down) (B) Proteins with down-regulated expression at 15 h then unchanged or up-regulated at 48 h post-irradiation (down-up). (C) Proteins with up-regulated expression at 15 h then unchanged or down at 48 h post-irradiation (up-down). (D) Proteins with up-regulated expression in 15 h and 48 h post-irradiation (up-up). Selection of significantly enriched terms (Benjamini-Hochberg P < 0.01(–log (P-value) >2.0)) was shown.
Fig. 6.Probable mechanism of cell cycle suspension induced by ionizing radiation. In 15 h/Ctrl group, cell cycle arrest might induced by these down-regulated proteins. In 48 h/Ctrl group, apoptosis was not observed and cell suspension emerged. The significantly changed proteins might play a vital role in cell growth, cell senescence and cell survival.